Apex Healthcare Bhd (APER)

Currency in MYR
2.490
0.000(0.00%)
Closed·
APER Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
APER is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.4602.490
52 wk Range
1.9002.840
Key Statistics
Bid/Ask
2.45 / 2.49
Prev. Close
2.49
Open
2.49
Day's Range
2.46-2.49
52 wk Range
1.9-2.84
Volume
44.8K
Average Volume (3m)
75.78K
1-Year Change
-11.7%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APER Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.217
Downside
-10.98%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Apex Healthcare Bhd Company Profile

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liquids and suspensions, creams, and sterile eye drops under the Xepa brand name. It also engages in the contract manufacturing of surgical grade orthopedic devices, components, and surgical instruments, as well as orthopedic components that are used in the surgical treatment of musculoskeletal disorders resulting from traumas, diseases, injuries, or deformities. In addition, the company is involved in the retail of pharmaceutical products; rental and management of properties; brand management activities; and provision of accounting and management consultancy services. Further, it commercializes pharmaceuticals, consumer healthcare products, and medical devices under the Zynexis brand name. The company was founded in 1962 and is headquartered in Malacca, Malaysia.

Employees
976
Market
Malaysia

Compare APER to Peers and Sector

Metrics to compare
APER
Peers
Sector
Relationship
P/E Ratio
24.6x21.6x−0.5x
PEG Ratio
−0.30−0.710.00
Price/Book
2.2x1.8x2.6x
Price / LTM Sales
1.9x1.8x3.2x
Upside (Analyst Target)
−13.7%21.9%41.7%
Fair Value Upside
Unlock18.3%6.1%Unlock

Analyst Ratings

0 Buy
3 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 2.217
(-10.98% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.10%
Dividend Yield
3.61%
Industry Median 4.17%
Annualised payout
0.09
Paid unevenly
5-Years Growth
+29.51%
Growth Streak

Earnings

Latest Release
May 21, 2025
EPS / Forecast
0.031 / --
Revenue / Forecast
238.90M / --
EPS Revisions
Last 90 days

APER Income Statement

FAQ

What Stock Exchange Does Apex Healthcare Trade On?

Apex Healthcare is listed and trades on the Kuala Lumpur Stock Exchange stock exchange.

What Is the Stock Symbol for Apex Healthcare?

The stock symbol for Apex Healthcare is "APER."

What Is the Apex Healthcare Market Cap?

As of today, Apex Healthcare market cap is 1.79B.

What Is Apex Healthcare's Earnings Per Share (TTM)?

The Apex Healthcare EPS (TTM) is 0.10.

When Is the Next Apex Healthcare Earnings Date?

Apex Healthcare will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is APER a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Apex Healthcare Stock Split?

Apex Healthcare has split 5 times.

How Many Employees Does Apex Healthcare Have?

Apex Healthcare has 976 employees.

What is the current trading status of Apex Healthcare (APER)?

As of 26 Jul 2025, Apex Healthcare (APER) is trading at a price of 2.49, with a previous close of 2.49. The stock has fluctuated within a day range of 2.46 to 2.49, while its 52-week range spans from 1.90 to 2.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.